The SFTCG Board awarded travel grants to four French participants of the ESGCT / SITGEC Collaborative Congress, which took place on 22-25 October 2024, in Rome, Italy.
Allwyn Pereira Université de Nantes
OR081 Assessing molecular mechanisms of microglial mediated inflammation in retinal gene therapy
Carine Bourdais Institute for Regenerative Medicine and Biotherapy (IRMB), Univ Montpellier, Inserm
P1012 Combined cellular and gene therapy to treat primary ciliary dyskinesia
Margaux Melka Grenoble Institute of Neurosciences
P0677 Development of CRISPR/Cas9 Gene Therapy for RYR1-Related Myopathies
Mauricio Saenz Institut Pasteur
P0346 Differential hearing restoration in the DFNB9 mouse model through AAV gene therapy with human and mouse cDNA